{"url":"https://lda.senate.gov/api/v1/filings/990fccbe-ccdc-45f0-8732-2b91c272bfce/","filing_uuid":"990fccbe-ccdc-45f0-8732-2b91c272bfce","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2022,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/990fccbe-ccdc-45f0-8732-2b91c272bfce/print/","filing_document_content_type":"text/html","income":null,"expenses":"27000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"S. Bradley Traverse","dt_posted":"2023-01-24T12:00:25-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"440 1st Street, NW","registrant_address_2":"Suite 430","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401105750,"url":"https://lda.senate.gov/api/v1/registrants/401105750/","house_registrant_id":null,"name":"INFUSION PROVIDERS ALLIANCE","description":"Healthcare Association","address_1":"610 10th St. NW","address_2":"Suite 300","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELLIOTT WARREN","contact_telephone":"+1 202-557-8983","dt_updated":"2026-07-20T10:21:59.863856-04:00"},"client":{"id":212363,"url":"https://lda.senate.gov/api/v1/clients/212363/","client_id":12,"name":"INFUSION PROVIDERS ALLIANCE","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-08-31"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; H.R. 5376, the Build Back Better Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":111972,"prefix":null,"prefix_display":null,"first_name":"BRAD","nickname":null,"middle_name":null,"last_name":"TRAVERSE","suffix":null,"suffix_display":null},"covered_position":"Former Senior Advisor, Office of the HHS Assistant Secretary of Public Affairs","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}